B M T APTALIS (Pylera bismuth subcitrate potassium 140 mg / metronidazole 125 mg / tetracycline hydrochloride 125 mg)
Generic Name: bismuth subcitrate potassium/metronidazole/tetracycline
Pill with imprint B M T APTALIS is White, Capsule-shape and has been identified as Pylera bismuth subcitrate potassium 140 mg / metronidazole 125 mg / tetracycline hydrochloride 125 mg. It is supplied by Allergan, Inc..
Pylera is used in the treatment of helicobacter pylori infection and belongs to the drug class H. pylori eradication agents. There is positive evidence of human fetal risk during pregnancy. Pylera bismuth subcitrate potassium 140 mg / metronidazole 125 mg / tetracycline hydrochloride 125 mg is not a controlled substance under the Controlled Substance Act (CSA).
Images for B M T APTALIS
- Generic Name:
- bismuth subcitrate potassium/metronidazole/tetracycline
- B M T APTALIS
- bismuth subcitrate potassium 140 mg / metronidazole 125 mg / tetracycline hydrochloride 125 mg
- Prescription only
- Drug Class:
- H. pylori eradication agents
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Allergan, Inc.
- National Drug Code (NDC):
More about Pylera (bismuth subcitrate potassium / metronidazole / tetracycline)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 120 Reviews – Add your own review/rating
- Drug class: H. pylori eradication agents
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.